12.07.2015 Views

JV - Award for Best Belgian Sustainability Report

JV - Award for Best Belgian Sustainability Report

JV - Award for Best Belgian Sustainability Report

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Kenya: implications <strong>for</strong> programmes? Trans R Soc Trop Med Hyg2011;105(8):421-30.Zolfo M, Bateganya MH, Adetifa IM, Colebunders R, Lynen L. Atelemedicine service <strong>for</strong> HIV/AIDS physicians working in developingcountries. J Telemed Telecare 2011;17(2):65-70.Zolfo M, Schapiro JM, Phan V, Koole O, Thai S, Vekemans M, Fransen K,Lynen L. Genotypic impact of prolonged detectable HIV-1 RNA viralload after HAART failure in a CRF01_AE infected cohort. AIDS Res HumRetroviruses 2011;27(7):727-35.Other publicationsApers L, Yansouni C, Soentjens P, Vekemans M, Bottieau E. The useof Interferon-gamma release assays <strong>for</strong> tuberculosis screening ininternational travelers. Curr Infect Dis Rep 2011;13(3):229-35.Burgmeijer R, Van Gompel A. Vaccinaties voor reizigers. In: BurgmeijerR, Hoppenbrouwers K, editors. Handboek vaccinaties. Deel A: Theorieen uitvoeringspraktijk; 2e herz.dr. Assen: Koninklijke Van Gorcum;2011:371-8.Clerinx J, Van Gompel A. Schistosomiasis in travellers and migrants.Travel Med Infect Dis 2011;9(1):6-24.Colebunders R. Cured of fear of flying [letter]. Travel Med Infect Dis2011;9(2):82.Croughs M. Acute mountain sickness. Ninth National Seminar onTravel Medicine; tailoring pre-travel advice to the individual traveller;Thursday 17 November 2011, Brussels, Belgium. [Brussels]: [s.n.]; 2011.Elliott JH, van Griensven J, McMahon J, Lynen L. Surrogate markersof antiretroviral efficacy. In: Gupta S, Kumar B, editors. Sexuallytransmitted infections; 2nd ed. New Delhi: Elsevier; 2011:826-30.García C, Llamocca LP, Garía K, Jiménez A, Samalvides F, Gotuzzo E,Jacobs J. Knowledge, attitudes and practice survey about antimicrobialresistance and prescribing among physicians in a hospital setting inLima, Peru. BMC Clin Pharmacol 2011;11(18):1-8.Heyman P, Ceianu C, Christova I, Tordo N, Beersma M, João Alves M,Lundkvist A, Hukic M, Papa A, Tenorio A, Zelená H, Essbauer S, Visontai I,Golovljova I, Connell J, Nicoletti L, Van Esbroeck M, Gjeruldsen DudmanS, Aberle S, Avsic-Zupanc T, Korukluoglu G, Nowakowska A, KlempaB, Ulrich R, Bino S, Engler O, Opp M, Vaheri A. A five-year perspectiveon the situation of haemorrhagic fever with renal syndrome andstatus of the hantavirus reservoirs in Europe, 2005-2010. Euro Surveill2011;16(36):pii=19961.Huis In ‘t Veld D, Colebunders R, van Griensven J. Monitoring bodyweight evolution in HIV care in resource-limited settings. TreatStrategies AIDS 2011;2(1):92-6.Jacobs F, Van Gompel A. Flashes from the 12th CISTM Boston - what’snew in travel medicine: WHO/CDS news. Ninth National Seminar onTravel Medicine; tailoring pre-travel advice to the individual traveller;Thursday 17 November 2011, Brussels, Belgium. [Brussels]: [s.n.]; 2011.Levy-Hara G, Amábile-Cuevas CF, Gould I, Hutchinson J, Abbo L,Saxynger L, Vlieghe E, Cardoso FLL, Methar S, Kanj S, OhmagariN, Harbarth S. “Ten Commandments” <strong>for</strong> the appropriate use ofantibiotics by the practicing physician in an outpatient setting. FrontMicrobiol 2011;2(230):1-7.Potters I, Van Esbroeck M. Fixatieven in de parasitologie. Tijdschr BelgVer Lab Technol 2011;38(3):163-6.Taha M, Deribew A, Tessema F, Assegid S, Duchateau L, ColebundersR. Risk factors of active tuberculosis in people living with HIV/AIDSin southwest Ethiopia: a case control study. Ethiop J Health Sci2011;21(2):131-9.Togun T, Peterson I, Jaffar S, Oko F, Okomo U, Peterson K, Jaye A. Pretreatmentmortality and loss-to-follow-up in HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients eligible <strong>for</strong> antiretroviral therapy in TheGambia, West Africa. AIDS Res Ther 2011;8(24):1-8.van Dijk DPJ, Dinant GJ, Jacobs JA. Inappropriate drug donations:what has happened since the 1999 WHO Guidelines? Educ Health2011;24(2):462.Van Gompel A. Jet lag. Ninth National Seminar on Travel Medicine;tailoring pre-travel advice to the individual traveller; Thursday 17November 2011, Brussels, Belgium. [Brussels]: [s.n.]; 2011.Van Gompel A, Van Meensel B, Lontie M. Chemoprofylaxe van malaria(21ste herwerking). [Leuven]: [MCH], 2011: 1 pp.Van Gompel A, Vandercam B. Conjugate or polysaccharide quadrivalentmeningococcal vaccine: no easy answer. Ninth National Seminar onTravel Medicine; tailoring pre-travel advice to the individual traveller;Thursday 17 November 2011, Brussels, Belgium. [Brussels]: [s.n.]; 2011.Van Gulck E, Heyndrickx L, Bracke L, Coppens S, Florence E, Buvé A,Lewi P, Vanham G. Control of viral replication after cessation of HAART.AIDS Res Ther 2011;8(6):1-5.Vlieghe E, Van Gompel A. Malaria op intensieve zorgen: a ‘hot topic’.In: VVIZW, editor. Jaarboek voor de intensievezorgenverpleegkundige2011. Acco: Leuven; 2011:85-92.Wootton R, Vladzymyrskyy A, Zolfo M, Bonnardot L. Experience withlow-cost telemedicine in three different settings. Recommendationsbased on a proposed framework <strong>for</strong> network per<strong>for</strong>mance evaluation.Glob Health Action 2011;4(7214):1-11.Zolfo M, Lorent N, Bateganya M, Kiyan C, Lequarré F, Koole O, LynenL. Telemedicine in HIV/AIDS care: a users’ satisfaction survey. In:Jordanova M, Lievens F, editors. Med@Tel, the international educationaland networking <strong>for</strong>um <strong>for</strong> ehealth, telemedicine and health ICT,Luxembourg, 14-16 April 2010. Luxembourg: International Society <strong>for</strong>Telemedicine and eHealth (ISfTeH); 2011:325-8.70 | ONDERZOEK

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!